HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chun-Bo Wang Selected Research

haishengsu

1/2018Tegillarca granosa extract Haishengsu inhibits tumor activity via a mitochondrial‑mediated apoptotic pathway.
5/2010Tegillarca granosa extract Haishengsu inhibits the expression of P-glycoprotein and induces apoptosis in drug-resistant K562/ADM cells.
10/2009Effect of haishengsu as an adjunct therapy for patients with advanced renal cell cancer: a randomized and placebo-controlled clinical trial.
10/2009Antitumor effect of the seashell protein Haishengsu on Ehrlich ascites tumor: an experimental study.
10/2009Cytotoxicity of natural extract from Tegillarca granosa on ovarian cancer cells is mediated by multiple molecules.
4/2009Effect of Haishengsu on transplanted K562 and drug-resistant K562/ADM tumors: an experimental study.
1/2009Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: a pilot randomized and placebo-controlled clinical trial.
1/2009Effect of a seashell protein Haishengsu on the immunological function of mice with Ehrlich ascites tumor.
1/2008Effect of a seashell protein Haishengsu on cell growth and expression of apoptosis genes in leukemia K562 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chun-Bo Wang Research Topics

Disease

5Neoplasms (Cancer)
10/2020 - 04/2009
2Leukemia
05/2010 - 01/2008
2Ehrlich Tumor Carcinoma
10/2009 - 01/2009
1Lung Injury
10/2020
1Inflammation (Inflammations)
10/2020
1Lung Diseases (Lung Disease)
10/2020
1Radiation Pneumonitis
10/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Chronic Disease (Chronic Diseases)
01/2011
1Liver Diseases (Liver Disease)
01/2011
1Neoplasm Metastasis (Metastasis)
10/2009
1Renal Cell Carcinoma (Grawitz Tumor)
10/2009
1Ovarian Neoplasms (Ovarian Cancer)
10/2009
1Weight Gain
10/2009
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2009
1Vomiting
01/2009
1Nausea
01/2009
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2009

Drug/Important Bio-Agent (IBA)

9haishengsuIBA
01/2018 - 01/2008
5Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2008
2Pharmaceutical PreparationsIBA
05/2010 - 04/2009
1Messenger RNA (mRNA)IBA
10/2020
1Interleukin-6 (Interleukin 6)IBA
10/2020
1CytokinesIBA
10/2020
16-methyladenineIBA
10/2020
1CaspasesIBA
01/2018
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2011
1Caspase 3 (Caspase-3)IBA
10/2009
1Cadherins (E-Cadherin)IBA
10/2009
1beta CateninIBA
10/2009
1CateninsIBA
10/2009
1Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2009
1Therapeutic UsesIBA
01/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2009

Therapy/Procedure

4Therapeutics
01/2018 - 01/2009
1Radiotherapy
10/2020
1Oral Administration
01/2018
1Immunotherapy
10/2009
1Drug Therapy (Chemotherapy)
01/2009